Valuation Zai Lab Limited Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 21:23:59 05/08/2026 +04			5-day change	1st Jan Change
15.85 ^EUR	-2.76%		-0.63%	+7.53%

08-03	Zai Lab Receives FDA Orphan Drug Designation for Zocilurtatug Pelitecan in Neuroendocrine Carcinomas	MT
07-29	Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	2,077	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	5.89%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,584	1,706	1,803
Change	-	-58.33%	-2.13%	10.47%	-33.34%	13.41%	7.71%	5.69%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-8.24x	-9.84x	-12.6x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.94x	4.42x	4.94x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.6x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.64x	3.49x	2.76x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.54x	2.87x	2.4x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.43x	-10.4x	-23.5x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-6.07x	-9.7x	-19.7x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-9.01x	-14.7x	-25.7x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-11.1%	-6.79%	-3.89%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.244	-1.88	-1.464
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	447.6	594.6	751.5
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-246.2	-163.3	-76.84
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-260.9	-175.9	-91.43
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-244.1	-158.9	-136.3
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-493.5	-371.4	-274.2
Reference price ²	62.85	30.70	27.33	26.19	17.64	18.49	18.49	18.49
Nbr of stocks (in thousands)	96,409	95,972	98,349	108,937	111,219	112,355	-	-
Announcement Date	01/03/22	01/03/23	27/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.72x	4.09x	9.62x	0.51%	75.96B
UCB	22.79x	4.95x	14.39x	0.65%	49.03B
SAMSUNG BIOLOGICS CO.,LTD.	35.94x	12.28x	23.37x	-.--%	47.88B
CSL LIMITED	-58.2x	3.39x	10.02x	3.15%	43.39B
BIOGEN INC.	37.93x	3.44x	12.89x	-.--%	30.8B
INCYTE CORPORATION	53.82x	3.4x	26.33x	-.--%	24.45B
MODERNA, INC.	-6.64x	9.07x	-5.85x	-.--%	22.75B
INNOVENT BIOLOGICS, INC.	64.19x	6.07x	41.78x	-.--%	19.24B
BRIDGEBIO PHARMA, INC.	-36.55x	17.57x	-48.07x	-.--%	16.04B
Average	14.55x	7.14x	9.39x	0.48%	36.62B
Weighted average by Cap.	14.08x	6.32x	11.93x	0.63%